John McKune

Officer, KalVista Pharmaceuticals, Inc.

Companies

Pulmonx CorpChief financial officer Oct 19, 2023 to Mar 7, 2024¹
KalVista Pharmaceuticals, Inc.Officer Aug 12, 2015 to Jan 5, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pulmonx Corp LUNG76,210 shares³$133.7K at $1.75Mar 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2024Granted 14,400 shares of Pulmonx Corp⁴
Mar 1, 2024Sold 669 shares at $9.06 of Pulmonx Corp⁴
Mar 1, 2024Sold 254 shares at $9.06 of Pulmonx Corp⁴
Mar 1, 2024Granted 28,800 shares of Pulmonx Corp³
Mar 1, 2024Sold 155 shares at $9.06 of Pulmonx Corp⁴
Dec 1, 2023Granted 7,233 shares of Pulmonx Corp⁵
Dec 1, 2023Sold 585 shares at $10.34 of Pulmonx Corp⁵
Dec 1, 2023Sold 222 shares at $10.34 of Pulmonx Corp⁵
Dec 1, 2023Sold 135 shares at $10.33 of Pulmonx Corp⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPulmonx Corp, Chief financial officer
2
SEC EDGARKalVista Pharmaceuticals, Inc., Officer
3
SEC EDGARPulmonx Corp shares after the filing of Mar 1, 2024
4
SEC EDGARForm 4 filed Mar 5, 2024
5
SEC EDGARForm 4 filed Dec 5, 2023